---
annotations:
- type: Pathway Ontology
  value: phagocytosis pathway
authors:
- ReactomeTeam
- DeSl
description: The Fc gamma receptors (FCGRs) have been reported to facilitate Leishmania
  internalization, especially when in its amastigote form (Ueno et al. 2012). Following
  cell-to-cell propagation within an established infection or reinfection of a previously
  infected host, the IgG produced by the host covers the surface of Leishmania amastigote
  parasites, making them more susceptible to phagocytosis through FCGRs (Polando et
  al. 2013).<br><br>Classically, phagocytosis via FCGRs has been associated with the
  subsequent activation of Rac GTPases and Cdc42 which in turn activate the phagocyte's
  NADPH oxidase, contributing to the activation of killing mechanisms (Ueno et al.
  2012).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9664422
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5000
- /instance/WP5000
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5000.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The Fc gamma receptors (FCGRs) have been reported to facilitate Leishmania
    internalization, especially when in its amastigote form (Ueno et al. 2012). Following
    cell-to-cell propagation within an established infection or reinfection of a previously
    infected host, the IgG produced by the host covers the surface of Leishmania amastigote
    parasites, making them more susceptible to phagocytosis through FCGRs (Polando
    et al. 2013).<br><br>Classically, phagocytosis via FCGRs has been associated with
    the subsequent activation of Rac GTPases and Cdc42 which in turn activate the
    phagocyte's NADPH oxidase, contributing to the activation of killing mechanisms
    (Ueno et al. 2012).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9664422
    Reactome].
  keywords:
  - 'Ig heavy chain V-II region MCE '
  - 'ATP '
  - 'CYFIP1 '
  - 'PI(4,5)P2 '
  - p-Y-WRC:IRSp53/58:RAC1:GTP:PIP3
  - 'Ig heavy chain V-III region DOB '
  - 'IGKV2D-30 '
  - CDC42:GTP
  - 'CD3G '
  - 'WAS '
  - 'Ig lambda chain V-III region LOI '
  - 'p-Y173-VAV3 '
  - 'CRK '
  - Lma amastigote
  - 'Ig lambda chain V-IV region Hil '
  - IgG:LPG1G2
  - 'Lma amastigote surface '
  - 'IGLV5-45(1-?) '
  - 'ABI1 '
  - 'PI(3,4,5)P3 '
  - 'CDC42 '
  - 'NCKIPSD '
  - 'Ig kappa chain V-II region RPMI 6410 '
  - 'Ig lambda chain V-II region MGC '
  - 'ARPC4 '
  - 'Ig kappa chain V-I region Daudi '
  - 'Ig kappa chain V-I region DEE '
  - 'Ig kappa chain V-III region VG '
  - ADP
  - 'IGLC7 '
  - surface:p-FCGR3A:p-6Y-SYK:CRKII:DOCK180:ELMO
  - WAVE Regulatory
  - filaments
  - 'GDP '
  - 'Ig lambda chain V-II region TOG '
  - 'WIPF2 '
  - (SFKs)
  - 'p-6Y-CD247 '
  - 'NCK1 '
  - 'BRK1 '
  - 'WASF3 '
  - surface:FCGR3Ap-CD3
  - 'IGKV2-28 '
  - BAIAP2
  - 'Ig kappa chain V-II region FR '
  - 'p-Y172-VAV2 '
  - 'IGHG2 '
  - 'p-Y151-WASF1 '
  - 'ARPC1A '
  - 'IGLV5-37(1-?) '
  - 'MYH2 '
  - 'p-Y150-WASF2 '
  - CDC42:GDP
  - 'IGLV1-36(1-?) '
  - 'IGLV3-16(1-?) '
  - 'BTK '
  - dimers
  - 'p-T185,Y187-MAPK1 '
  - 'Ig lambda chain V-I region NEWM '
  - 'ABI2 '
  - antigens:FCGR3A:CD3
  - 'BAIAP2 '
  - 'IGLV7-43(1-?) '
  - 'IGLC6 '
  - 'NCKAP1 '
  - 'Ig lambda chain V region 4A '
  - 'IGHV(1-?) '
  - 'F-actin '
  - 'LPG1G2 '
  - 'VAV2 '
  - 'Ig heavy chain V-I region EU '
  - 'ARPC1B '
  - p-T,Y MAPK dimers
  - 'p-T202,Y204-MAPK3 '
  - F-actin
  - ATP
  - 'Ig kappa chain V region EV15 '
  - 'Ig heavy chain V-II region ARH-77 '
  - 'GRB2-1 '
  - 'IGLV10-54(1-?) '
  - 'IGHG1 '
  - 'PTK2 '
  - IgG:Lma antigens
  - 'IGLC3 '
  - 'WIPF3 '
  - PI(3,4,5)P3
  - 'IGLV7-46(1-?) '
  - surface
  - 'PI(3,4)P2 '
  - 'NCKAP1L '
  - 'YES1 '
  - complex:daughter
  - 'p-Y160,Y171-CD3G '
  - Complex
  - 'Ig kappa chain V-I region AU '
  - filament
  - 'VAV1 '
  - GTP
  - SH3 domain proteins
  - 'ACTR3 '
  - 'N-WASP '
  - ARP2/3 complex (ATP
  - IgG:Leishmania
  - 'p-Y151,S,T-WASF3 '
  - 'IGLV3-12(1-?) '
  - filament:ARP2/3:actin:ADP
  - CRK:DOCK180:ELMO1,ELMO2
  - PI(4,5)P2:WASP/N-WASP
  - Mother
  - 'FYN '
  - 'IGLV8-61(1-?) '
  - 'Ig kappa chain V-III region POM '
  - 'IGKV1-5(23-?) '
  - 'MYO10 '
  - 'FGR '
  - 'ARPC3 '
  - LPG1G2
  - 'CYFIP2 '
  - 'MYO1C '
  - G-actin
  - 'p-Y174-VAV1 '
  - WIP family proteins
  - 'IGLC1 '
  - 'IGKC '
  - 'IGKV3D-20 '
  - 'Ig heavy chain V-III region JON '
  - 'p-Y256-WASL '
  - 'Ig heavy chain V-II region OU '
  - 'IGLV(23-?) '
  - 'IGLV3-27(1-?) '
  - CDC42:GTP:WASP/N-WASP
  - 'Ig lambda chain V-II region NEI '
  - 'Ig lambda chain V-IV region Kern '
  - 'ACTR2 '
  - 'MYO9B '
  - Myosin-X
  - RAC1:GTP
  - 'Ig heavy chain V-II region NEWM '
  - p-Y,S,T-WRC:IRSp53/58:RAC1:GTP:PIP3
  - Myosin-Actin
  - 'Ig kappa chain V-II region Cum '
  - 'IGLV2-23(1-?) '
  - 'IGLV4-60(1-?) '
  - 'ACTB(1-375) '
  - 'IGLV4-69(1-?) '
  - surface:FCGR3A
  - PIP3:VAV1,2,3
  - 'Ig heavy chain V-III region TRO '
  - 'p-4S-ABI2 '
  - IgG:Lma amastigote
  - 'IGHV1-2 '
  - 'IGKV4-1(21-?) '
  - antigens:FCGR3A:p-CD3 dimers
  - 'LYN '
  - 'ELMO2 '
  - 'p-Y151-WASF3 '
  - bound)
  - 'p-Y150,S343,T346-WASF2 '
  - Pi
  - WAVE2, WASP, N-WASP
  - surface:p-FCGR3A:p-6Y-SYK:p-VAV1,2,3:PI(3,4,5)P3
  - 'ELMO1 '
  - 'p-5S-ABI1 '
  - Unknown GEF
  - 'Ig lambda chain V-II region BOH '
  - 'ADP '
  - VAV1,2,3
  - Src family kinases
  - 'IGLV11-55(1-?) '
  - 'SYK '
  - 'Ig lambda chain V-I region NEW '
  - N-WASP:ARP2/3
  - 'IgH  heavy chain V-III region VH26 precursor '
  - 'IGLV3-22(1-?) '
  - 'WASF1 '
  - CDC42:GTP:WASP/N-WASP:WIP:SH3 proteins
  - 'FCGR3A '
  - 'Ig heavy chain V-III region KOL '
  - 'IGHG4 '
  - 'Ig heavy chain V-II region WAH '
  - 'IGLV2-11(1-?) '
  - 'p-6Y-SYK '
  - WRC:IRSp53/58:RAC1:GTP:PIP3
  - 'ARPC5 '
  - complex
  - 'Ig kappa chain V-I region HK101 '
  - 'IGKV1-12 '
  - 'Ig lambda chain V-I region HA '
  - 'Ig kappa chain V-III region B6 '
  - 'RAC1 '
  - 'p-Y291-WAS '
  - 'MYH9 '
  - ABL1
  - PI(4,5)P2
  - 'Ig kappa chain V-I region AG '
  - 'IGLV3-25(1-?) '
  - 'IGHG3 '
  - 'IGHV7-81(1-?) '
  - 'IGLC2 '
  - antigens:FCGR3A:p-CD3 dimers:p-6Y-SYK
  - FCGRIIIA:CD3G/CD3Z
  - 'Ig kappa chain V-I region Gal '
  - 'Ig kappa chain V-I region BAN '
  - 'HCK '
  - 'WASF2 '
  - GDP
  - CDC42:GTP:p-Y-WASP/p-Y-WASL:WIP:SH3 proteins
  - complex:G-actin
  - dimers:p-6Y-SYK:VAV1,2,3:PI(3,4,5)P3
  - filament:branching
  - IgG:Lma
  - 'Ig heavy chain V-III region BUT '
  - 'CD247-1 '
  - 'MYO5A '
  - Src-kinases
  - 'IGKVA18(21-?) '
  - IgG
  - 'Ig heavy chain V-III region CAM '
  - 'ARPC2 '
  - 'WIPF1 '
  - 'IGLV1-44(1-?) '
  - WASP/N-WASP
  - 'Ig lambda chain V-I region VOR '
  - 'Ig kappa chain V-I region Wes '
  - 'ACTG1 '
  - SYK
  - 'IGLV2-33(1-?) '
  - PI(3,4)P2
  - 'GTP '
  - 'Ig lambda chain V-VI region AR '
  - 'Ig heavy chain V-III region BRO '
  - 'Ig heavy chain V-I region HG3 '
  - 'Ig lambda chain V-III region SH '
  - 'IGLV2-18(1-?) '
  - 'SRC-1 '
  - Actin filament bound
  - 'VAV3 '
  - 'DOCK1 '
  - Myosin
  - 'IGLV1-40(1-?) '
  - RAC1:GDP
  - 'p-Y151,S,T-WASF1 '
  - Myosin-X dimer
  - antigens:FCGR3A:p-CD3 dimers:SYK
  - 'Ig lambda chain V-IV region Bau '
  - WAVE2, WASP,
  - 'Ig heavy chain V-III region WEA '
  - 'IGLV4-3(1-?) '
  license: CC0
  name: FCGR3A-mediated phagocytosis
seo: CreativeWork
title: FCGR3A-mediated phagocytosis
wpid: WP5000
---